LKB1 mutation in large cell carcinoma of the lung

Lung Cancer

Volumn 53, Issue 3, 2006, Pages 285-294

  Zhong, Diansheng ^a   Guo, Lizheng ^a   de Aguirre, Itziar ^a,b   Liu, Xiuju ^a   Lamb, Neil ^a   Sun, Shi Yong ^a   Gal, Anthony A ^a   Vertino, Paula M ^a   Zhou, Wei ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Adenocarcinomas; AMPK signaling; Large cell carcinomas; LKB1; Mutation; Non small cell lung carcinoma (NSCLC); Tumor suppressor gene

Indexed keywords

AMINO ACID; DEOXYGLUCOSE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN KINASE LKB1;

ALLELE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENERGY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXON; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE MAPPING; GENE MUTATION; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG CARCINOMA; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TARGETING; STRESS;

ALLELES; AMP-ACTIVATED PROTEIN KINASES; CARCINOMA, LARGE CELL; CELL LINE, TUMOR; DNA, COMPLEMENTARY; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GREEN FLUORESCENT PROTEINS; HOMOZYGOTE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MULTIENZYME COMPLEXES; MUTATION; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES;

EID: 33746905916     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.05.018     Document Type: Article

References (42)

1. Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S., Loukola A., et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391 6663 (1998) 184-187
2. Jenne D.E., Reimann H., Nezu J., Friedel W., Loff S., Jeschke R., et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18 1 (1998) 38-43
3. Boardman L.A., Thibodeau S.N., Schaid D.J., Lindor N.M., McDonnell S.K., Burgart L.J., et al. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 128 11 (1998) 896-899
4. Giardiello F.M., Brensinger J.D., Tersmette A.C., Goodman S.N., Petersen G.M., Booker S.V., et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119 6 (2000) 1447-1453
5. Giardiello F.M., Welsh S.B., Hamilton S.R., Offerhaus G.J., Gittelsohn A.M., Booker S.V., et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316 24 (1987) 1511-1514
6. Lim W., Hearle N., Shah B., Murday V., Hodgson S.V., Lucassen A., et al. Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. Br J Cancer 89 2 (2003) 308-313
7. Collins S.P., Reoma J.L., Gamm D.M., and Uhler M.D. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem J 345 Pt 3 (2000) 673-680
8. Luukko K., Ylikorkala A., Tiainen M., and Makela T.P. Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development. Mech Dev 83 1-2 (1999) 187-190
9. Karuman P., Gozani O., Odze R.D., Zhou X.C., Zhu H., Shaw R., et al. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell 7 6 (2001) 1307-1319
10. Yoo L.I., Chung D.C., and Yuan J. LKB1-a master tumour suppressor of the small intestine and beyond. Nat Rev Cancer 2 7 (2002) 529-535
11. Avizienyte E., Loukola A., Roth S., Hemminki A., Tarkkanen M., Salovaara R., et al. LKB1 somatic mutations in sporadic tumors. Am J Pathol 154 3 (1999) 677-681
12. Avizienyte E., Roth S., Loukola A., Hemminki A., Lothe R.A., Stenwig A.E., et al. Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors. Cancer Res 58 10 (1998) 2087-2090
13. Bignell G.R., Barfoot R., Seal S., Collins N., Warren W., and Stratton M.R. Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer. Cancer Res 58 7 (1998) 1384-1386
14. Wang Z.J., Churchman M., Campbell I.G., Xu W.H., Yan Z.Y., McCluggage W.G., et al. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours. Br J Cancer 80 1-2 (1999) 70-72
15. Sobottka S.B., Haase M., Fitze G., Hahn M., Schackert H.K., and Schackert G. Frequent loss of heterozygosity at the 19p13.3 locus without LKB1/STK11 mutations in human carcinoma metastases to the brain. J Neurooncol 49 3 (2000) 187-195
16. Rowan A., Bataille V., MacKie R., Healy E., Bicknell D., Bodmer W., et al. Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas. J Invest Dermatol 112 4 (1999) 509-511
17. Guldberg P., thor Straten P., Ahrenkiel V., Seremet T., Kirkin A.F., and Zeuthen J. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene 18 9 (1999) 1777-1780
18. Sanchez-Cespedes M., Parrella P., Esteller M., Nomoto S., Trink B., Engles J.M., et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 62 13 (2002) 3659-3662
19. Carretero J., Medina P.P., Pio R., Montuenga L.M., and Sanchez-Cespedes M. Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene 23 22 (2004) 4037-4040
20. Goldberg E.K., Glendening J.M., Karanjawala Z., Sridhar A., Walker G.J., Hayward N.K., et al. Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis. Am J Hum Genet 67 2 (2000) 417-431
21. Chen C., Brabham W.W., Stultz B.G., Frierson Jr. H.F., Barrett J.C., Sawyers C.L., et al. Defining a common region of deletion at 13q21 in human cancers. Genes Chromosomes Cancer 31 4 (2001) 333-344
22. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93 18 (1996) 9821-9826
23. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95 5 (1998) 2509-2514
24. Esteller M., Avizienyte E., Corn P.G., Lothe R.A., Baylin S.B., Aaltonen L.A., et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 19 1 (2000) 164-168
25. Hawley S.A., Davison M., Woods A., Davies S.P., Beri R.K., Carling D., et al. Characterization of the AMP-activated protein kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271 44 (1996) 27879-27887
26. Stein S.C., Woods A., Jones N.A., Davison M.D., and Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345 Pt 3 (2000) 437-443
27. Wang Z.J., Taylor F., Churchman M., Norbury G., and Tomlinson I. Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes. Am J Pathol 153 2 (1998) 363-366
28. Dong S.M., Kim K.M., Kim S.Y., Shin M.S., Na E.Y., Lee S.H., et al. Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res 58 17 (1998) 3787-3790
29. Launonen V., Avizienyte E., Loukola A., Laiho P., Salovaara R., Jarvinen H., et al. No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas. Cancer Res 60 3 (2000) 546-548
30. Mulshine J.L., Cuttitta F., Bibro M., Fedorko J., Fargion S., Little C., et al. Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. J Immunol 131 1 (1983) 497-502
31. Casero Jr. R.A., Baylin S.B., Nelkin B.D., and Luk G.D. Human lung tumor sensitivity to difluoromethylornithine as related to ornithine decarboxylase messenger RNA levels. Biochem Biophys Res Commun 134 2 (1986) 572-579
32. Casero Jr. R.A., Go B., Theiss H.W., Smith J., Baylin S.B., and Luk G.D. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine. Cancer Res 47 15 (1987) 3964-3967
33. Phelps R.M., Johnson B.E., Ihde D.C., GazdarAF, Carbone D.P., McClintock P.R., et al. NCI-navy medical oncology branch cell line data base. J Cell Biochem Suppl 24 (1996) 32-91
34. brambilla E., Pugatch B., Geisinger K., and Gal A. Large cell carcinoma. In: Travis W.D., Bramilla E., Muller-Hermelink H.K., and Harris C.C. (Eds). Pathology and genetics of tumours of the lung, pleura, thymus, and heart (2004), World Health Organization 45-50
35. Pelosi G., Fraggetta F., Pasini F., Maisonneuve P., Sonzogni A., Iannucci A., et al. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol 25 3 (2001) 363-372
36. Wang B.Y., Gil J., Kaufman D., Gan L., Kohtz D.S., and Burstein D.E. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol 33 9 (2002) 921-926
37. Davies H., Hunter C., Smith R., Stephens P., Greenman C., Bignell G., et al. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 65 17 (2005) 7591-7595
38. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13 22 (2003) 2004-2008
39. Hardie D.G., Carling D., and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?. Annu Rev Biochem 67 (1998) 821-855
40. Mu J., Brozinick Jr. J.T., Valladares O., Bucan M., and Birnbaum M.J. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7 5 (2001) 1085-1094
41. Travis W.D. Pathology of lung cancer. Clin Chest Med 23 1 (2002) 65-81 [viii]
42. Beadsmoore C.J., and Screaton N.J. Classification, staging and prognosis of lung cancer. Eur J Radiol 45 1 (2003) 8-17